Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
The lab of The Wistar Institute’s Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
New research has identified a promising strategy against treatment-resistant melanoma: inhibiting the S6K2 gene.
PHILADELPHIA — (February 5, 2025) —The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. The ...
News Medical on MSN13d
Inhibiting S6K2 gene offers potential treatment for drug-resistant melanomaThe lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .
When Abbott Fund offered Christy Wistar EMP-56 the position of vice president in 2006, the job came with a caveat: She had to move to Tanzania. Wistar liked the idea at first, especially since the ...
As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...
PHILADELPHIA, PA, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The lab of The Wistar Institute’s Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback